Amoéba successfully completes a €9.7 million capital increase

Amoéba, a company specializing in natural microbiological solutions, has successfully completed its rights issue, raising €9.7 million. The transaction resulted in the issuance of 32,294,779 new shares, each accompanied by a warrant, at a price of €0.30 per share. The support of majority shareholder Nice & Green was crucial, with the conversion of €6 million in debt, significantly reducing the company's debt.

The settlement and delivery of the shares and warrants on Euronext is scheduled for October 29, 2026. The funds raised cover Amoéba's financial needs until September 2027. The future monetization of the WillaTM cosmetics platform should eliminate the need for further fundraising by 2029. The transaction strengthens the financing of current and commercial activities, ensuring significant savings in financial costs.